<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>15(1)</volume><submitter>Suzuki K</submitter><funding>Academic Society for Research in Otolaryngology, Kansai Medical University</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>Secretory carcinoma (SC) of the salivary gland is a recently described malignant tumor harboring characteristic ETV6-NTRK3 gene fusion. SC generally has a favorable clinical course, and is currently regarded as a low-grade carcinoma. However, a small subset of SCs demonstrates aggressive clinical features with histologically high-grade transformed morphology, the molecular pathogenesis of which has not yet been elucidated. In this study, we performed a clinicopathological and molecular genetic study of patients with SC of the head and neck displaying various clinical characteristics to investigate the differences of pathological and molecular genetics between low-grade and high-grade components of SC.&lt;h4>Case presentation&lt;/h4>Three cases with SC of the head and neck, inc</pubmed_abstract><journal>BMC medical genomics</journal><pagination>6</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8739673</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Clinicopathological investigation of secretory carcinoma cases including a successful treatment outcome using entrectinib for high-grade transformation: a case report.</pubmed_title><pmcid>PMC8739673</pmcid><pubmed_authors>Kanda A</pubmed_authors><pubmed_authors>Harada H</pubmed_authors><pubmed_authors>Takeda M</pubmed_authors><pubmed_authors>Iwai H</pubmed_authors><pubmed_authors>Ohe C</pubmed_authors><pubmed_authors>Kawahara A</pubmed_authors><pubmed_authors>Suzuki K</pubmed_authors><pubmed_authors>Sawada S</pubmed_authors><pubmed_authors>Uemura Y</pubmed_authors><pubmed_authors>Sengupta B</pubmed_authors></additional><is_claimable>false</is_claimable><name>Clinicopathological investigation of secretory carcinoma cases including a successful treatment outcome using entrectinib for high-grade transformation: a case report.</name><description>&lt;h4>Background&lt;/h4>Secretory carcinoma (SC) of the salivary gland is a recently described malignant tumor harboring characteristic ETV6-NTRK3 gene fusion. SC generally has a favorable clinical course, and is currently regarded as a low-grade carcinoma. However, a small subset of SCs demonstrates aggressive clinical features with histologically high-grade transformed morphology, the molecular pathogenesis of which has not yet been elucidated. In this study, we performed a clinicopathological and molecular genetic study of patients with SC of the head and neck displaying various clinical characteristics to investigate the differences of pathological and molecular genetics between low-grade and high-grade components of SC.&lt;h4>Case presentation&lt;/h4>Three cases with SC of the head and neck, inc</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jan</publication><modification>2025-05-31T22:24:54.566Z</modification><creation>2025-05-31T22:24:54.566Z</creation></dates><accession>S-EPMC8739673</accession><cross_references><pubmed>34991563</pubmed><doi>10.1186/s12920-022-01155-6</doi></cross_references></HashMap>